Back | Next |
home / stock / ctxr / ctxr message board
Subject | By | Source | When |
---|---|---|---|
$CTXR MomentumIts gaining | shurtha2000 | investorshub | 04/09/2023 4:41:16 AM |
$CTXR The now last up | Foxwoods Man | investorshub | 04/08/2023 8:01:45 AM |
$CTXR MomentumIts trading | green maschine | investorshub | 04/06/2023 11:08:43 PM |
$CTXR MomentumIts trading | green maschine | investorshub | 04/05/2023 2:39:21 PM |
Price gaining | marylandstockguy | investorshub | 04/04/2023 3:18:28 PM |
whytestocks: $CTXR News Article - Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of H | whytestocks | investorshangout | 04/03/2023 12:15:46 PM |
A bit of news - Citius extends gains | drkazmd65 | investorshub | 03/30/2023 6:41:21 PM |
whytestocks: $CTXR News Article - Citius Pharmaceuticals Advances Efforts to Spin Off Oncology Asset | whytestocks | investorshangout | 03/30/2023 3:55:48 PM |
Who cares about E7777??? | KJAX | investorshub | 03/01/2023 11:13:03 PM |
Fairly evenhanded article on Seeking Alpha this morning | drkazmd65 | investorshub | 03/01/2023 2:26:48 PM |
Your son left money on the table! $CTXR | DTL | investorshub | 02/02/2023 2:48:19 PM |
Maybe I am missing something but $CTXR closed | Foxwoods Man | investorshub | 01/26/2023 11:48:31 AM |
I just spoke with my son and he | longboarder7892 | investorshub | 01/24/2023 8:16:00 PM |
$10 by July? ?? | sfld | investorshub | 01/19/2023 8:13:35 PM |
I see my son was right again on | longboarder7892 | investorshub | 01/19/2023 6:27:38 PM |
Looks like the presentation was received with enthusiasm | drkazmd65 | investorshub | 01/18/2023 8:39:37 PM |
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2022 | longtrailer | investorshub | 12/23/2022 4:02:20 PM |
2023 could develop into a very good year | drkazmd65 | investorshub | 12/01/2022 9:13:49 PM |
whytestocks: $CTXR News Article - Citius Pharmaceuticals, Inc. Announces U.S. Food and Drug Administ | whytestocks | investorshangout | 12/01/2022 8:15:49 PM |
F/Y/I Citius Pharmaceuticals, Inc. Announces U.S. Food and Drug | Diana15 | investorshub | 12/01/2022 12:45:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Citius Pharmaceuticals Inc. Company Name:
CTXR Stock Symbol:
NASDAQ Market:
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma PR Newswire National Cancer Institute (NCI)-designated research and treatment center City of Hope, in Duarte, CA , to ...
Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference PR Newswire CRANFORD, N.J. , April 4, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedic...
Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma PR Newswire FDA assigns Prescription Drug User Fee Act (PDUFA) target action date ...